Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Post-inflammatory Hyperpigmentation: later-stage trial registry
A small indexed set (4 trials) with no open enrollment listed right now.
Corpus placement: #4,115 of 28,707 conditions by registered trial count.
4 US clinical trials · none currently recruiting · #4,115 of 28,707 conditions by registered trial count
Post-inflammatory Hyperpigmentation: 4 US clinical trials tracked, none currently recruiting.
Post-inflammatory Hyperpigmentation is the subject of 4 registered US clinical trials on ClinicalTrials.gov, none currently recruiting. 1 are in Phase 3-4 (later-stage) and 0 in Phase 1-2 (earlier-stage). The most active sponsor is Derm Research, P, running 1 of these trials.
Enrollment posture brief
Registry condition post-inflammatory-hyperpigmentation
OPEN 0 | RECR 0% | LATE 1 | EARLY 0 | RANK #4115 | SPON 1
Volume-matched condition peers
Nearest open-share peer: Accelerated Phase Chronic Myelogenous Leukemia (0% recruiting · 12 trials)
Post-inflammatory Hyperpigmentation has no open enrollment in this registry pull (4 archived studies). Peers show how other volume-matched labels compare on open share. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for Post-inflammatory Hyperpigmentation on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
Post-inflammatory Hyperpigmentation is recruiting below its size-band peers.
0 of 4 indexed trials (0%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
Indexed trials (enrollment closed)
4 total, page 1 of 1
An In Vivo Model for Postinflammatory Hyperpigmentation
Henry Ford Health System
NCT02905903
The Effects of Cetyl Tranexamate Mesylate on the Appearance of Acne-Related Hyperpigmentation
Integrative Skin Science and Research
NCT06080035
The Use of Onexton in Moderate Acne Vulgaris for Patients With Skin of Color
Derm Research, P
NCT03402893
A Novel Regimen for Treatment and Prevention of Post-Inflammatory Hyperpigmentation in Skin of Color
Narrows Institute for Biomedical Research
NCT06938815
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 4 | 1 |
Top Sponsors
Named interventions
Most-linked intervention names on Post-inflammatory Hyperpigmentation records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on Post-inflammatory Hyperpigmentation trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this Post-inflammatory Hyperpigmentation page
4 registered trials, 0 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- No Post-inflammatory Hyperpigmentation trials are currently recruiting in this registry; that can change as new trials post, or check the broader research index. Browse research indexes
- Derm Research, P sponsors the most Post-inflammatory Hyperpigmentation trials on record, review their full trial history before evaluating a specific study. See Derm Research, P's trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Post-inflammatory Hyperpigmentation condition card totals 4 registered trials; most-linked intervention ONEXTON Topical Gel; top US site state New York. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.